Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin for Exam Indicated Cerclage
NCT05132829Phase 4Unknown
- Sponsor
- Thomas Jefferson University
- Start
- Dec 2021
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of azithromycin in preterm birth, sponsored by Thomas Jefferson University. Status: unknown.
02
Drugs
azithromycin
03
Conditions
preterm birth
Beyond the preview
Go deeper on NCT05132829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05132829.